Adaptavir

1. Adaptavir - CAS 106362-34-9 A CCR5 receptor antagonist. CCR5 antagonists block HIV from getting into and infecting certain cells of the immune system. Please be kindly noted that our product can only be used for research to orgnizations or companies and we don't cooperate with personal buyers. Category Inhibitor Targets CCR SARS-CoV-2 Molecular Formula C35H56N10O15 Molecular Weight 856.9 Chemical Information Category Inhibitor Molecular Formula C35H56N10O15 Molecular Weight 856.9 Specification Properties Reference Reading Sequence Sequence H-D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 Appearance Appearance White Solid

2. Synonyms Synonyms RAP-101; D-Ala-1-peptide T-NH-2; DAPTA; mDAPTA; Monomeric (D-Alanine-1) Peptid e T amide Solubility Solubility Soluble to 1 mg/ml in water. Storage Storage Desiccate at -20°C Clinical Trial Information NCT Number NCT Number Title Title Condition Condition Or Disease Or Disease Phase Phase Start Start Date Date Sponsor Sponsor Status Status NCT00951743 Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment- Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs) HIV Infections Phase 2 July 2009 Rapid Laboratories Inc. Unknown status Preparing Stock Solutions 1 mg 1 mg 5 mg 5 mg 10 mg 10 mg ConcentrationVolumeMass ConcentrationVolumeMass 1 mM 1.1670 mL 5.8351 mL 11.6702 mL 5 mM 0.2334 mL 1.1670 mL 2.3340 mL 10 mM 0.1167 mL 0.5835 mL 1.1670 mL 50 mM 0.0233 mL 0.1167 mL 0.2334 mL https://www.bocsci.com/dapta-cas-106362-34-9-item-358434.html